论文部分内容阅读
临床资料例1,女,27岁,1986年6月因颈前区包块而手术,术后病理为甲状腺滤泡癌(病理号861761×2);因此到我科口服大剂量~(131)Ⅰ治疗。检查:颈前区刀口Ⅰ期愈合,甲状腺局部未触及结节,浅表淋巴结不肿大;全身r相机检查:甲状腺右叶缺如,左叶残余甲状腺组织显像,肺、骨未见有放射性物质浓聚,血象正常,首次口服~(131)Ⅰ3700MBq,以后每隔三个月一次口服治疗,共用三次,总剂量为6190MBq,每次服药后有轻微恶心乏力,食欲减退。三次大剂
Clinical data Example 1, female, 27 years old, surgery in June 1986 due to mass in the anterior cervical mass, postoperative pathology of thyroid follicular carcinoma (pathological number 861761×2); therefore, oral high dose to our department ~ (131) I treatment. Examination: In the anterior cervical region, the wound healed on the first stage, no thyroid nodules were touched, and superficial lymph nodes were not swollen; whole body r camera examination: lack of right thyroid lobe, residual thyroid tissue imaging in the left lobe, no radioactivity in the lungs and bones. The substance was concentrated and the blood was normal. The first oral administration was (131) I3700 MBq. Oral treatment was given once every three months and shared three times. The total dose was 6190 MBq. There was slight nausea and fatigue and loss of appetite after taking each dose. Three large agents